Coexistence of three variants involving two different fusion partners of ROS1 including a novel variant of ROS1 fusions in lung adenocarcinoma: a case report.
*Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Medical School Cancer Institute, Shanghai, People's Republic of China; and †Translational Medical Center, Xiamen University, Xiamen, People's Republic of China.
Weijing
W
Cai
Wei
W
Li
Shengxiang
S
Ren
Limou
L
Zheng
Xuefei
X
Li
Caicun
C
Zhou
D000230:Adenocarcinoma / Q000235:genetics* / Q000556:secondary; D000944:Antigens, Differentiation, B-Lymphocyte / Q000235:genetics; D001932:Brain Neoplasms / Q000556:secondary*; D005260:Female; D015321:Gene Rearrangement; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D008207:Lymphatic Metastasis; D008875:Middle Aged; D050596:Oncogene Fusion; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb / Q000235:genetics
D000944:Antigens, Differentiation, B-Lymphocyte; D000949:Histocompatibility Antigens Class II; D011518:Proto-Oncogene Proteins; C493557:SLC34A2 protein, human; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb; C045084:invariant chain; D011505:Protein-Tyrosine Kinases; C062333:ROS1 protein, human